Displaying drugs 301 - 325 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| rhThrombin | Not Annotated |  | Investigated for use/treatment in blood (blood forming organ disorders, unspecified) and hemorrhage. | Not Annotated |
| Albumin iodinated I-125 serum | Not Annotated | | A radiopharmaceutical diagnostic agent indicated for use in the determination of total blood and plasma volume. | Radioactive Diagnostic Agent |
| Albumin iodinated I-131 serum | Not Annotated | | A radiopharmaceutical diagnostic agent indicated for use in the determination of total blood and plasma volume and other diagnostic purposes. | Radiopharmaceutical Activity |
| Albumin Aggregated | Not Annotated | | Albumin aggregated is an ingredient in the DRAXIMAGE MAA kit for the preparation of technetium tc99m albumin aggregated injection, which is indicated for the assessment of lung perfusion and for... | Radioactive Diagnostic Agent |
| Von Willebrand factor human | Not Available |  | A blood clotting factor used to manage bleeding episodes in von Willebrand disease and hemophilia A. | Blood Coagulation Factors / von Willebrand Factor / von Willebrand Factor, antagonists & inhibitors |
| Plasminogen | Not Available | | Plasma-derived human plasminogen administered intravenously to treat type 1 plasminogen deficiency (hypoplasminogenemia). | Anticoagulants / Beta-Globulins / Enzyme Precursors / Fibrinolytic Agents |
| Antithrombin Alfa | Not Available | | A recombinant antithrombin used to treat peri-operative and peripartum thromboembolic events in hereditary antithrombin deficiency. | Recombinant Antithrombin |
| Antithrombin III human | Not Available | | An alpha-2-glycoprotein used to prevent thromboembolisms in patients with hereditary antithrombin III deficiency. | Alpha-Globulins / Antithrombin III / Antithrombin III, agonists / Antithrombin Proteins / Blood Coagulation Factor Inhibitors |
| Thrombomodulin Alfa | Not Available | | Investigated for use/treatment in blood preservative, blood (blood forming organ disorders, unspecified), sepsis and septicemia, and thrombosis. | Amino Acids, Peptides, and Proteins / Carbohydrates / Glycoconjugates / Glycoproteins / Membrane Glycoproteins / Membrane Proteins / Platelet Membrane Glycoproteins / Proteins / Receptors, Peptide / Receptors, Thrombin |
| Human cord blood hematopoietic progenitor cell | Not Available | | A set of stem cells derived from umbilical cord blood used for stem cell donation to unrelated recipients. | Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy |
| Lenograstim | Not Available | | A granulocyte colony-stimulating factor indicated in the reduction of duration of neutropenia in bone marrow transplant and cytotoxic chemotherapy, as well as mobilizing hematopoietic stem cells in healthy donors. | Colony-Stimulating Factors |
| Methoxy polyethylene glycol-epoetin beta | Not Available | | A synthetic erythropoiesis stimulating agent (ESA) used to treat anemia associated with chronic kidney disease. | Erythropoiesis-Stimulating Agents |
| Interferon alfa-n3 | Not Available |  | A purified form of human interferon used to stimulate the innate antiviral response in the treatment of genital warts due to human papilloma virus. | Interferon alpha |
| Efalizumab | Not Available |  | A monoclonal anti-CD11a antibody used to treat moderate to severe plaque psoriasis. | Selective Immunosuppressants |
| Palivizumab | Not Available |  | A monoclonal anti respiratory syncytial virus F protein antibody used to prevent serious sequelae caused by respiratory syncytial virus infection in pediatric patients. | Antiviral monoclonal antibodies / Specific Immunoglobulins |
| Panitumumab | Not Available |  | A recombinant humanized monoclonal antibody used to treat EGFR-expressing, metastatic colorectal carcinoma that is refractory to fluoropyrimidine-, oxaliplatin-, and irinotecan- containing chemotherapy regimens. | Antibodies, Monoclonal / EGFR (Epidermal Growth Factor Receptor) inhibitors |
| Idarucizumab | Not Available |  | An antibody that binds dabigatran for the reversal of anticoagulant effects of dabigatran. | Antidotes |
| Necitumumab | Not Available |  | A monoclonal antibody used to treat metastatic squamous non-small cell lung cancer. | Antibodies, Monoclonal / EGFR (Epidermal Growth Factor Receptor) inhibitors |
| Brodalumab | Not Available | | A monoclonal antibody used to treat moderate to severe plaque psoriasis. | Interleukin Inhibitors |
| Lebrikizumab | Not Available | | An IgG4 monoclonal antibody against IL-13 used to treat moderate-to-severe atopic dermatitis in adults and adolescents. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Blood Proteins / Globulins / Immunoglobulins / Immunoproteins / Proteins / Serum Globulins |
| Mogamulizumab | Not Available | | A monoclonal antibody used to treat relapsed or refractory mycosis fungoides or Sézary syndrome after attempting one other therapy. | Antibodies, Monoclonal / Chemokine Receptor Type 4 Interaction |
| Ibalizumab | Not Available | | A CD4-specific antibody used to treat HIV infections. | Anti-HIV Agents / CD4-directed Blocking Antibody / HIV Fusion Inhibitors / Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor |
| Bimekizumab | C6552H10132N1750O2029S42 | | An anti-IL-17A, IL-17F, and IL-17AF monoclonal antibody used in the treatment plaque psoriasis. | Interleukin Inhibitors |
| Antilymphocyte immunoglobulin (horse) | Not Available | | A primarily IgG immune globulin used to manage allograft rejection in renal transplant patients. | Selective Immunosuppressants |
| Capromab pendetide | Not Available |  | A monoclonal anti-prostate specific membrane antigen antibody used in imaging kits to target radioactive agents to malignant prostate tissue. | Indium (111In) Compounds |
Displaying drugs 301 - 325 of 406 in total